Natco Pharma (BOM:524816) Operating Cash Flow per Share : ₹0.00 (TTM As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Natco Pharma Operating Cash Flow per Share?

Natco Pharma's operating cash flow per share for the three months ended in Mar. 2024 was ₹0.00. Natco Pharma's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Natco Pharma was 45.10% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 60.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 10.20% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 14.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Natco Pharma's Operating Cash Flow per Share or its related term are showing as below:

BOM:524816' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -58.7 Med: 18.9 Max: 76.7
Current: 60.3

During the past 13 years, Natco Pharma's highest 3-Year average Operating Cash Flow per Share Growth Rate was 76.70% per year. The lowest was -58.70% per year. And the median was 18.90% per year.

BOM:524816's 3-Year OCF Growth Rate is ranked better than
92.18% of 806 companies
in the Drug Manufacturers industry
Industry Median: 7.5 vs BOM:524816: 60.30

Natco Pharma Operating Cash Flow per Share Historical Data

The historical data trend for Natco Pharma's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Natco Pharma Operating Cash Flow per Share Chart

Natco Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Operating Cash Flow per Share

Get a 7-Day Free Trial

22.87

16.37

2.55

46.51

67.50

Natco Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Natco Pharma's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Natco Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Natco Pharma's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Natco Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Natco Pharma's Price-to-Operating-Cash-Flow falls into.

Natco Pharma Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Natco Pharma's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (A: Mar. 2024 )	=	Cash Flow from Operations (A: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2024 )
	=	12116	/	179.506
	=	67.50

Natco Pharma's Operating Cash Flow per Share for the quarter that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	0	/	179.121
	=	0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00

Natco Pharma Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Natco Pharma's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Natco Pharma (BOM:524816) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Natco Pharma Ltd (BOM:524816) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

NATCOPHARM:India

Address

Road No. 2, NATCO House, Banjara Hills, Hyderabad, TG, IND, 500034

Website

https://www.natcopharma.co.in

Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.

Natco Pharma (BOM:524816) Headlines

No Headlines